ArticleDermatology and therapy2026
Treatment Patterns and Burden of Atopic Dermatitis in Adults in the United Arabic Emirates, Saudi Arabia, Kuwait, Qatar and Turkey: A Real-World Study.
Article in Dermatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionUnderstanding of real-world clinical practice for patients with atopic dermatitis (AD) in the Middle East is limited. We aimed to describe clinical characteristics, treatment patterns and disease burden for adult patients.
methodsData were drawn from the Adelphi Real World AD Disease Specific Programme™, a cross-sectional survey of qualified dermatologists and their patients in the United Arab Emirates, Kingdom of Saudi Arabia, Kuwait, Qatar and Turkey between September 2022 and March 2023. Dermatologists reported patient demographics, clinical characteristics and treatment history. Patients reported the Patient-Oriented Eczema Measure (POEM), Dermatology Life Quality Index (DLQI), EQ-5D-5L, and Work Productivity and Activity Impairment questionnaire.
resultsOverall, 209 dermatologists reported data on 736 patients, of whom 437 self-reported data. Dermatologists subjectively determined that 200 patients had 'mild', 283 had 'moderate' and 253 had 'severe' AD at survey. Mean (SD) patient age was 28.8 (8.1) years; 50% were male and 50% female. Overall mean (SD) POEM scores were 9.7 (5.5), DLQI were 9.7 (5.5), EQ-5D-5L were 0.72 (0.29) and overall work impairment was 46.0% (22.3%). Majority were prescribed topical treatments (89%), 18% received systemic immunosuppressants and 13% received biologics.
conclusionsOur findings highlight the disease burden and need to use more efficacious treatment in the Middle East, to improve clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.